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Background: Shoulder arthritis of varied aetiology is often disabling and patients seek treatment for pain relief and
restricted movements. Though non operative measures in the form of analgesics, physiotherapy and joint injections
offer satisfactory results in the early stages; operative treatment in the form of joint replacements becomes
necessary in late and advanced stages. The above operations are being performed more frequently in the recent
years across the National Health Service [NHS] in the UK with increasing success in specialised units and the
outcome of the operation is often rewarding. In addition to the other complications, risks of Deep vein thrombosis
[DVT] and pulmonary embolism [PE] exists. Available evidence suggests a low incidence but the true risk has only
been partially addressed. The final decision to consider thromboprophylaxis rests with the operating surgeon. It is
important to carefully balance the clinical decision of thromboprophylaxis and bleeding with wound complications,
which add considerable morbidity and mortality. To define the risk of DVT in this subgroup of patients is the initial
step to enable better use of resources and achieve cost effectiveness. This we believe will provide robust evidence
to help formulate guidelines for thromboprophylaxis in shoulder arthroplasty.
Methods/design: The aim will be to determine whether shoulder arthroplasties carry a risk of DVT. A cohort of 100
consecutive patients being considered for shoulder arthroplasty for degenerative arthritis, rotator cuff arthropathy,
inflammatory arthropathy including rheumatoid arthritis will be prospectively included for the study. All eligible
patients will be assessed clinically and screened for DVT in all 4 limbs both pre and postoperative with Doppler
scans within a 6 week perioperative period. We aim to include the reasons for non inclusion of eligible patients and
patient’s perspective of their general well being in relation to DVT.
Discussion: We present the risk of DVT associated with shoulder arthroplasties to establish a good quality evidence
for thromboprophylaxis. The study is underway and we would further be able to define whether the general risk
factors for DVT are relevant to shoulder replacements.
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We aim to improve the quality of available evidence of
whether shoulder arthroplasties carry a risk of DVT. This
will help us to determine the need for thromboprophylaxis.Background
Shoulder arthritis of varied aetiology is often disabling
and patients seek treatment for pain relief and restricted
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distribution, and reproduction in any mediumof analgesics, physiotherapy and joint injections offer
satisfactory results in the early stages; operative treat-
ment in the form of joint replacements becomes neces-
sary in late and advanced stages. The above operations
are being performed more frequently in the recent years
across the National Health Service [NHS] in the UK
with increasing success in specialised units and the out-
come of the operation is often rewarding. In addition to
the other complications, risks of Deep vein thrombosis
[DVT] and pulmonary embolism [PE] exists. Several
case reports, retrospective studies, surgeon surveys,
database reviews and results from the National joint
registry, UK reports a low incidence [1-6] of DVT. TheCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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one study [7]. NICE guidelines [8] recommend risk as-
sessment and offering mechanical and or chemoprophy-
laxis routinely for all patients undergoing upper limb
surgery. We intend improving the quality of available evi-
dence. The final decision to consider thromboprophylaxis
rests with the operating surgeon. It is important to care-
fully balance the clinical decision of thromboprophylaxis
and bleeding with wound complications, which add con-
siderable morbidity and mortality. To define the risk of
DVT in this subgroup of patients is the initial step to en-
able better use of resources and achieve cost effectiveness.
This we believe will provide robust evidence to help for-
mulate guidelines for thromboprophylaxis in shoulder
arthroplasty.
Methods
We intend to conduct a prospective cohort study to as-
sess the risk of DVT in shoulder arthroplasties. This
includes systematic collection of data and study of base-
line characteristics from all eligible patients, irrespective
of their participation in the study. As detailed below, the
study emphasizes standard protocols within the NHS
trust with well defined patient management pathways.
This has been possible following consultations and inter-
actions with the medical and haematology departments
within the NHS trust.
The patient continues to be under the care of the
orthopaedic team until safe discharge and therefore we
anticipate we will be able to complete the study with a
less likelihood of patients ‘dropping out’ of the study. All
untoward events including mortality and the relevant
reasons will be documented. The study group is repre-
sentative of the population which will therefore not
threaten the external validity of the study.
Inclusion criteria
All patients with suitable clinical symptoms and signs of
arthritis who are anaesthetic fit for shoulder arthroplasty
will be included in the study. Shoulder arthroplasty in-
cludes total shoulder replacement, hemiarthroplasty and
reverse shoulder arthroplasty. The main indications for
shoulder arthroplasty will be degenerative arthritis and
rotator cuff arthropathy.
Exclusion criteria
 Patients positive for DVT on pre operative Doppler
scanning
 Patients with co morbidities requiring
anticoagulation, including previous malignancies and
previously identified coagulation disorders.
 Patients who will not be able to follow up for other
reasons.Brief details of the practical arrangements for recruitment
All patients will be clinically examined and assessment is
completed with standard views of plain radiographs pre-
operatively. The proposed procedure including the na-
ture of the operation contemplated, risks, routine
postoperative care including physiotherapy and follow-
up, expected outcome will be discussed. The purpose of
the proposed study will be discussed and if the patient is
willing, shall be included in the study. An information
leaflet which will briefly describe the nature of the prob-
lem investigated will be given to the patients included
for the study. The patients are then consented for inclu-
sion in the study in addition to the site specific consent
for the operative procedure. With the patient’s permis-
sion, letters will be sent to their General practitioners
[GP] to inform them of participation. We will request
patient permission to allow us to ask their GP to provide
information on their contact details if we are unable to
contact them directly.
Pre operative work up
Blood tests including coagulation profile [Fibrinogen
levels, prothrombin time, and Activated prothrombin
time], metabolic work up for liver and renal functions,
and additional investigations depending on the co-
morbidities will be completed as part of the pre opera-
tive assessment. All patients will be screened with pre
operative 4 limbs Doppler scans within 3 weeks from
the date of the operation. Patients with asymptomatic
DVT detected on Doppler scanning, will be excluded
from the study and further be referred to the concerned
medical team for further management. Those patients
who are negative for DVT on screening will proceed for
the operative procedure which will be as per prescribed
standards. With screening, we have therefore obliviated
the need for a separate control group.
Peri-operative management
Peri-operative management will include anaesthesia, an-
algesia, antibiotic administration and shoulder arthrop-
lasty performed in beach chair position as per routine
standards. No patient will be prescribed chemical
thromboprophylaxis. However all routine mechanical
intra-operative precautions will be followed.
Post operative management
All patients will be assessed and physiotherapy will be
supervised by a qualified physiotherapist before dis-
charge. We promote the need to encourage patients to
perform home exercises and the physiotherapist will
provide all the guidance and illustrative material. The
operating surgeon or his deputy will request postopera-
tive 4 limb Doppler scans before discharge along with
arrangements for follow up. We aim to arrange Doppler
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tion that most patients would be clinically comfortable
to be able to co operate and also considering the existing
load within the NHS framework. Similar prospective
study reports a lower incidence of DVT at 6 weeks in
contrast to a higher incidence at 2 days on scans. This
may reflect a natural trend for clots to dissolve within
the body system [7]. We therefore have chosen to ar-
range postoperative scans around 3–4 weeks to provide
meaningful information about the occurrence of DVT.
All radiology scans will be performed by suitably quali-
fied and trained radiographers. All reports will be vali-
dated by a consultant radiologist and will be uploaded
and stored on the hospital radiology software system
which will be used for data analysis. All patient data will
be stored confidential as per the NHS recommendations.
Doppler scans positive for DVT in the postoperative
period will be managed as per agreed and established
guidelines of DVT. All discharged patients will be
followed up for any untoward incidents before the
scheduled follow up, with a communication sent to the
general practitioner. At the scheduled postoperative fol-
low up, the scan results will be reviewed and discussed
with the patient.
Ethics and impact on participants
MREC approval has been obtained from North West
Wales research ethics committee [Ref: 08/WNo01/35].
As outlined above we are looking to provide good qual-
ity evidence and the investigation methods employed
have been well established as safe and effective for
screening purposes. We therefore do not anticipate any
additional risk to the patients or compromising on the
safety, with all standardised protocols followed through-
out the period of the study.
The participant informant sheet [PIS] has been devel-
oped to provide a balanced account of the problem
which is being addressed and clearly explain the objec-
tives of the study without compromising on the quality
of care. This will be the case whether the participant de-
cides to enter the study or decides not to consent. Writ-
ten informed consent is obtained from all recruited
subjects. All relevant documentation will be stored along
with the patient notes as stipulated within the NHS
framework.
Data collection
Basic scientific data for all patients recruited will be
done systematically and documented. Also we would
note, wherever possible, the reasons for patient opting
out of the study either at entry or midway. The relevant
data collected will include ethnicity, education status,
hand dominance, co morbidities, smoking, patient con-
tact details, GP name and surgery. The process will bemade simplistic and easily retrievable. The data collec-
tion for the above problem stops at the scheduled first
visit postoperative when we should have the scan results
available.
Sample size
The primary question addressed in this study is whether
shoulder arthroplasty increases the risk of deep vein
thrombosis. From previous available data, it is expected
that the rate of DVT will be approximately 13% in shoul-
der arthroplasty [7]. With this assumed value and with a
CI of 8–21, we propose to include 100 participants for
shoulder arthroplasty to achieve a power of over 80% [83%
actual] of finding a significant effect at 5% level. The actual
numbers will be probably less than the projected and
therefore our estimate of 10% drop-outs is purposely pes-
simistic for sample size calculations.
Period of study and data dissemination
The study is underway and our recruitment period is 24 -
months. We anticipate that recruitment will be challenging
particularly across the other sites. We shall endeavour to
achieve the target within the stipulated period. To achieve
our required numbers, we may include other similar NHS
sites in the study depending on the progress and this will
be in accordance with the stipulated regulations. Study
completion includes submission of the final report to the
BCUHB research committee, the funders to the project and
dissemination of the findings through relevant national and
international conferences and peer reviewed publications.
Discussion
This article is the version 3 [24/11/2009] of the protocol
for the study. This has been approved by the ethics com-
mittee after various suggestions and adjustments were
made to the original protocol. Many changes were made
in keeping with the required standards of research and
clarifications in wording the PIS and the consent form.
All changes have resulted in increased clarity and we
hope this will increase the effectiveness of the study.
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